Abstract
A size exclusion liquid chromatography (SE-LC) method was validated for the determination of erythropoietin in pharmaceutical formulations without serum albumin. The LC method was carried out on a BioSep-SEC-S 2000 column (300 mm × 7.8 mm I.D.) using photodiode array (PDA) detection at 214 nm. The mobile phase consisted of 0.001 M monobasic potassium phosphate, 0.008 M dibasic sodium phosphate, and 0.2 M sodium chloride buffer, pH 7.4, run isocratically at a flow rate of 0.5 mL/min. The chromatographic separation was obtained with retention time of 14.5 min, and was linear in the range of 5–150 µg/mL (r 2 = 0.9991). The accuracy was 101.07% with bias lower than 1.36%. The limits of detection and quantitation were 0.28 and 1 µg/mL, respectively. Moreover, method validation demonstrated acceptable results for precision and robustness. The proposed method was applied for the analysis of the erythropoietin in pharmaceutical dosage forms, and the content/potencies correlated to the bioassay, contributing to establish alternatives which improve the quality control, assuring the therapeutic efficacy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
